Quarterly report · Q2

Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥2.4bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥3.7bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥1.7bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥669m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥559m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥675m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.1bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥565m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥684m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥588m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥458m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥763m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥406m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥458m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥406m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥5.6bnat 2024-03-31Cons.Assets
Total assets¥5.7bnat 2023-09-30Cons.Assets
Total assets¥6.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥2.5bnat 2023-09-30Cons.Liabilities
Net assets / equity¥3.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥3.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥2.8bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥2.9bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥2.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥438m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥339m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥194m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥842m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥242m2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥434m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.3bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥405m2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.652023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.272024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.082022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥8.552022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.062023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.582022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥8.092022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio60.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio43.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥21m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥613m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥15m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.6bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥1m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥641m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥285m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥281m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥4m
jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥34m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥5m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥690m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥52,000
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥52,000
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥3m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥384m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥384m
jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥10m
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue2022-10-01 → 2023-03-31¥1.4bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.4bn
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥52,000
jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segmentsegment profit2022-10-01 → 2023-03-31¥553m
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥1.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-10-01 → 2023-03-31¥52,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥563m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 539
ItemContextValueUnit
Miscellaneous loss noePrior1YTDDuration179000JPY
Miscellaneous loss noeCurrentYTDDuration91000JPY
Non operating expensesPrior1YTDDuration2752000JPY
Non operating expensesCurrentYTDDuration8550000JPY
Ordinary incomePrior1YTDDuration565174000JPY
Ordinary incomeCurrentYTDDuration675282000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration22622000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration2814000JPY
Gain on sales of subsidiaries and affiliates stocks eiPrior1YTDDuration-JPY
Gain on sales of subsidiaries and affiliates stocks eiCurrentYTDDuration5897000JPY
Extraordinary incomePrior1YTDDuration22622000JPY
Extraordinary incomeCurrentYTDDuration8712000JPY
Income before income taxesPrior1YTDDuration587797000JPY
Income before income taxesCurrentYTDDuration683994000JPY
Income taxes currentPrior1YTDDuration183902000JPY
Income taxes currentCurrentYTDDuration220937000JPY
Income taxes deferredPrior1YTDDuration-1832000JPY
Income taxes deferredCurrentYTDDuration4986000JPY
Income taxesPrior1YTDDuration182069000JPY
Income taxesCurrentYTDDuration225923000JPY
Profit lossPrior1YTDDuration405727000JPY
Profit lossCurrentYTDDuration458071000JPY
Profit loss attributable to owners of parentPrior1YTDDuration405727000JPY
Profit loss attributable to owners of parentCurrentYTDDuration458071000JPY
Profit lossPrior1YTDDuration405727000JPY
Profit lossCurrentYTDDuration458071000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration-1165000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration2580000JPY
Other comprehensive incomePrior1YTDDuration-1165000JPY
Other comprehensive incomeCurrentYTDDuration2580000JPY
Comprehensive incomePrior1YTDDuration404561000JPY
Comprehensive incomeCurrentYTDDuration460651000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration404561000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration460651000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration587797000JPY
Income before income taxesCurrentYTDDuration683994000JPY
Depreciation and amortization ope cfPrior1YTDDuration126240000JPY
Depreciation and amortization ope cfCurrentYTDDuration148064000JPY
Amortization of goodwill ope cfPrior1YTDDuration9289000JPY
Amortization of goodwill ope cfCurrentYTDDuration27483000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration3337000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration1315000JPY
Interest income ope cfPrior1YTDDuration-111000JPY
Interest income ope cfCurrentYTDDuration-259000JPY
Interest income on securities ope cfPrior1YTDDuration-399000JPY
Interest income on securities ope cfCurrentYTDDuration-JPY
Surrender value of insurance ope cfPrior1YTDDuration-JPY
Surrender value of insurance ope cfCurrentYTDDuration-6548000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass